Background: Numerous factors pertaining to poor medication adherence in chronically ill
Notwithstanding this lack of information, many observed risk factors are amenable to potential 23 interventions, establishing a solid foundation for appropriate ongoing behaviors. Future research 24 should continue investigating questions pertaining to initial prescriptions, emerging treatment 25 barriers, and organizational efforts to promote better long-term adherence. pertaining to poor medication adherence in chronically ill patients are well documented.
37
However, there exists a paucity of studies concerning experiences during the early treatment 38 course (often referred to as either "primary, initial, or first fill adherence"), representing a crucial 39 knowledge gap. Accurately determining the rate of initial adherence is a challenge, because there 40 is currently no validated, systematic means of determining this through existing records.
41
However, in a national study comprising the vast majority of retail pharmacy prescriptions in the 42 U.S., the prevalence of new fill abandonment was 6.3% in 2009, up from 5.1% the prior year [2] .
43
The problem with the measurement of initial adherence stems from an inability to connect the 44 actions that occur in the physician's office with the patient's actions outside the physician's 45 office. In a survey of more than 9,000 patients, the Boston Consulting Group (BCG) reported 46 that 18% of patients did not fill a prescription in the past 12 months, with 10% giving as a 47 primary reason for nonadherence that they "can't get prescription filled, picked up or delivered"
48
[3]. Other small, non-generalizable studies about the rate of initial adherence do exist, but are 49 insufficient to establish a true estimate of the rate of initial non-adherence. These studies have 50 only either only studied specific conditions such as asthma [4] 
Results

112
Search Results:
113
Overall, the search of key terms identified 865 potentially relevant abstracts, of which 114 307 publication titles were deemed potentially eligible and the abstracts reviewed for additional 115 details. Of these, only 63 papers were determined to be likely relevant and therefore evaluated in 116 full by the entire study team to determine final inclusion. Based upon our definition of primary 117 or initial adherence which eliminated studies more broadly documenting early treatment compliance, longitudinal persistence, or discontinuation over periods ranging from 1 month to 119 two years after the first prescription, only 24 articles made our final eligibility list. These 120 selected publications were then fully extracted and evaluated for quality per the aforementioned 121 description. Table 1 articles thoroughly reviewed, 39 were excluded since although one of key search terms was used, 183 it was clear that the studies did not examine the very first prescription. Instead, our review team determined these articles presenting adherence findings over a period covering the early course 185 of treatment, which ranged from about a month to over a year following the index prescription.
186
As such, although these abstracts were picked up when using our search terminology (see Table   187 xxx 2?), they were not appropriate for our more rigid definition of initial or first-fill adherence. 
Behavioral Factors Associated with Poor Initial Adherence
230
Turning to the primary outcome of interest here, the authors also collectively examined 231 numerous issues associated with initial adherence identified in these papers, arriving at a 232 consensus of the most commonly reported psychosocial or behavioral risk factors. colleagues compared three drug classes over a longer time period (i.e., outcomes of no fill, or 264 only one fill during a 2-year window), finding that high cholesterol prescriptions were filled at 265 only half the rate of antihypertensive and hyperglycemic drugs [14] . Also examining two [24], yet on the outpatient side, those originating from primary care physicians were filled more 333 often than patients seeing specialist providers [19] .
334
Poor clinical response to treatment, either from past patient experiences or the very first 335 course of a new prescription, was found to be negatively associated with early adherence [9, 14]; 336 not surprisingly, medication side effects also reduced the likelihood of adherence, thought this 337 was directly examined in only one study [9] . A variety of other factors associated with initial adherence were noted, infrequently presented but contributing to the information pool. These 339 included a lower likelihood for electronic prescriptions to be filled [16] Additional text from Craig: Further, it was the only term that when used in conjunction with a compliance term uniquely identified an eligible publication as its use in the one ineligible publication was with therapy (i.e. primary therapy), which is not a compliance term. Initial was the second most commonly used term, observed in 42% (10 of 24) of the eligible publications, but it was almost as common at 38% in the ineligible. First-Fill was the third most commonly used term, being used almost 4 times as frequently in eligible publications than in the ineligible (38% vs. 10%). Abandonment and redemption were the only key compliance terms that were exclusively associated with eligible articles, however, adherence was used exclusively in eligible articles when associated with first-fill. 
Final eligible articles N = 24
Excluded by initial review and discussion of abstracts N = 243
